OssDsign

OssDsign Current Assets

The Current Assets of OssDsign (OSSD.ST) as of Nov 3, 2026 is 246.40 M SEK. In the previous year, Current Assets was 144.70 M SEK — a change of 70.28% (higher).

Current Assets

246.40 MSEK

YoY

70.28%

Last updated:

Current Assets of OssDsign is 2025 246.40 M SEK. Current Assets of OssDsign was 2024 144.70 M SEK. It decreases by 70.28% higher compared to the previous year.

The OssDsign Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
39.47 M SEK
Jan 1, 2019
130.14 M SEK
Jan 1, 2020
61.39 M SEK
Jan 1, 2021
170.24 M SEK
Jan 1, 2022
147.86 M SEK
Jan 1, 2023
200.38 M SEK
Jan 1, 2024
144.70 M SEK
Jan 1, 2025
246.40 M SEK
The OssDsign Current Assets history
YEARCurrent AssetsYoY
246.40 MSEK+70.28%
144.70 MSEK-27.78%
200.38 MSEK+35.52%
147.86 MSEK-13.15%
170.24 MSEK+177.28%
61.39 MSEK-52.82%
130.14 MSEK+229.75%
39.47 MSEK-0.71%
39.75 MSEK+140.29%
16.54 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OssDsign Stock analysis

What does OssDsign do? OssDsign AB develops and sells medical technology products, focusing on implantable solutions for bone healing, particularly in skull surgery. Its primary product, Craniomosaic, is an implant for skull defect repair (cranioplasty), while it also develops bioceramic implants for facial bone augmentation. The company uses proprietary bioceramic technologies that integrate with tissues and support bone ingrowth. Customers include neurosurgeons, craniofacial, and maxillofacial surgeons who purchase these products for surgical procedures. The company generates revenue through the development and sales of its medical technology products, specifically Craniomosaic and bioceramic implants for facial bone augmentation. These products are sold to surgeons specializing in skull and facial bone procedures. The firm’s focus on proprietary bioceramic technologies differentiates its offerings in the medical device market, targeting healthcare professionals who require advanced solutions for bone healing challenges. OssDsign AB’s business model centers on selling implantable medical devices developed using its unique bioceramic technologies. The company’s main customers are neurosurgeons, craniofacial surgeons, and maxillofacial surgeons who use Craniomosaic and facial bone augmentation implants during surgical operations. Revenue is derived from the direct sale of these products to medical professionals for clinical applications in bone healing and reconstruction. OssDsign is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OssDsign stock

Current Assets of OssDsign is 246.40 M SEK in 2025.

Current Assets of OssDsign changed from 144.70 M SEK to 246.40 M SEK, representing a 70.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets OssDsign since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's OssDsign historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — OssDsign

All Key Metrics — OssDsign